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Despite early recanalization of an occluded infarct artery, tissue reperfusion remains impaired in more than one-third of the acute
myocardial infarction (AMI) patients owing to a process of reperfusion injury. The role of systemic inﬂammation in triggering this
phenomenon is unknown. Proinﬂammatory factors (hs-CRP, TNF-α) and anti-inﬂammatory mediators (IL-1 receptor antagonist,
IL-10) were measured in 65 patients during the acute phase of a myocardial infarction as well as in 11 healthy control subjects. My-
ocardial reperfusion injury was deﬁned as the presence of persistent ST-segment elevation despite successful coronary intervention
(≥ 50% of the initial value) and was observed in 28 patients. Systemic proinﬂammatory mediators (particularly hs-CRP and leuko-
cytes) were higher in AMI patients compared to control subjects. Within the group of AMI patients, only serum TNF-α diﬀered
signiﬁcantly between patients with versus without reperfusion injury: a median value of 25 versus 13pg/mL was observed, respec-
tively. Logistic regression analysis identiﬁed a high level of TNF-α as the most important independent determinant of reperfusion
injury (P = .001), beyond total ischemic time (P = .01) and extent of jeopardized myocardium (P = .08). There was no corre-
lation between the TNF-α level and the total ischemic time (P = .8) or the extent of jeopardized myocardium (P = .6). Systemic
inﬂammation, in particular high levels of TNF-α, is strongly associated with the occurrence of reperfusion injury after successful
recanalization. Our ﬁndings suggest that TNF-α is involved in the triggering and/or ampliﬁcation of local inﬂammatory responses
related to ischemia-reperfusion injury.
INTRODUCTION
Despite successful early recanalization of an occluded
infarct artery by percutaneous coronary intervention
(PCI) or thrombolysis, up to one-third of AMI patients
still fail to obtain complete myocardial reperfusion due
to a process of myocardial reperfusion injury [1, 2]. This
phenomenon is characterised by an impairment of mi-
crocirculatory ﬂow and by ongoing ischemia and tissue
necrosis [3, 4]. Although the underlying mechanisms of
reperfusion injury are still not fully elucidated, there is
accumulating evidence that local inﬂammatory responses
with inﬁltration of leucocytes in the capillary circulation
and release of oxygen-free radicals play a key role in this
reperfusion-related tissue injury [5, 6]. However, the oc-
currence and the extent of reperfusion injury is variable
and is not solely related to the severity and duration of
myocardial ischemia [2, 7]. Whether the pre-existing sys-
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temic inﬂammatory state might be another important de-
terminant of this phenomenon is unknown.
Accordingly, this study was designed to compare the
systemic inﬂammatory state in AMI patients with ver-
sus without reperfusion injury. Systemic inﬂammatory
state was evaluated in the acute phase by measuring both
proinﬂammatory mediators (hs-CRP, TNF-α) as anti-




Between September 2003 and April 2004, a total of
65 patients with AMI lasting < 12 hours were prospec-
tivelyandconsecutivelyincludedandunderwentimmedi-
ate coronary angiography and percutaneous coronary in-
tervention if needed. All included patients showed initial
> 0.1mV ST-segment elevation in at least two contigu-
ous electrocardiographic leads and had 12-lead electro-
cardiogramavailablebeforeandattheendofthecoronary
intervention. All patients showed adequate restoration of
coronary patency (thrombolysis in myocardial infarction386 Fien Blancke et al 2005:6 (2005)
(TIMI) ﬂow grade ≥ 2) at the end of the procedure. Pa-
tients with left bundle-branch block or with poorly inter-
pretable ST-segments, were excluded. Arterial blood sam-
ples for measurements of the inﬂammatory status were
collected at the time of cardiac catheterisation and were
storedat −80◦Caftercentrifugation.Thestudygroupwas
stratiﬁed according to the presence or absence of reperfu-
sion injury as was assessed on serial ST-segment measure-
ments. The data of this study group were compared with
a control group of 11 healthy subjects.
The study was approved by the institutional ethical
committee of the Antwerp University Hospital and in-
formed consent was obtained from all patients.
Electrocardiographicanalysis
To assess the presence of myocardial reperfusion in-
jury, serial ST-segment analysis on a 12-lead electrocar-
diogram was obtained before and after successful recanal-
isation of the infarct artery (i.e., before discharge from the
catheterisation laboratory). The sum of the ST-segment
elevations was measured manually with lens-intensiﬁed
calipers 20 milliseconds after the end of the QRS complex
from leads I, aVL, and V1 through V6 for left anterior
descending artery occlusions and leads II, III, aVF, V5,
V6, and reciprocal ST-segment depressions in V1-2 for
right coronary/left circumﬂex occlusions. Persistent ST-
segment elevation, expressed as a percentage of the ini-
tial ST-segment elevation (%ST), was used as an electri-
cal marker of reperfusion injury and has been shown to
correlatewellwithimpairedmyocardialreperfusionatthe
microcirculatory level [7, 8]. Persistent ST-segment eleva-
tion, equal or more than 50% of the initial value (ST =
50%) was deﬁned as severely impaired myocardial reper-
fusion with ongoing tissue injury. On the other hand, ST-
segmentelevationsoflessthan50%(ST< 50%)indicated
good myocardial reperfusion without signiﬁcant ongoing
tissue injury. We have demonstrated a good reproducibil-
ity of these measurements in previous reports [9].
Laboratorydata
Measurements of tumor necrosis factor alfa (TNF-α),
interleukin- 10 (IL-10), interleukin-1 receptor antagonist
(IL-1ra) were performed using ELISA with reagents from
BenderMedSystems(Vienna,Austria)(forTNF-αandIL-
10) and R & D Systems (Minneapolis, Minn, USA) (for
IL-1 ra). The intra-assay variances for all ELISA measure-
ments were < 5%. Plasma CRP was measured by a high-
sensitivity latex particle turbidimetric assay (Wakao). The
lower limit of sensitivity of this method is 0.01mg/dL.
Angiographicdata
Coronary angiographic data were quantitatively anal-
ysed with a computer-based cardiovascular angiography
analysis system (CAAS II, Pie Medical Data, The Nether-
lands). Multivessel disease was deﬁned as the presence of
a lesion with > 50% diameter stenosis in a noninfarct
related coronary artery. The thrombolysis in myocardial
infarction (TIMI) angiographic scale was used to deter-
mine the recanalisation status of the infarct-related artery
andwasassessedvisually.TIMIblushgradewasappliedto
assess microcirculatory ﬂow after intervention [10]. TIMI
blush grade 0-1 reﬂects poor myocardial perfusion.
Clinicaldata
Thetotalischemictimecouldberegisteredadequately
in 64 patients and was deﬁned as the time from the be-
ginning of pain to the recanalisation of the occluded in-
farct artery. In case of an open artery at the time of car-
diac catheterization, total ischemic time was deﬁned as
the time from the beginning of the pain until resolution
of pain after initiation of thrombolytic therapy.
Treatment with thrombolytic therapy, glycoprotein
IIb/IIIa receptor antagonists, and stent use were left at the
discretion of the treating physician.
Patients were followed up to one month with data be-
ing recorded from clinic visits and/or telephone calls to
the referral physician. Two major adverse cardiac events
(MACE) were identiﬁed: cardiac death including sudden
death without evidence of a noncardiac origin and non-
fatal myocardial infarction. Myocardial infarction was de-
ﬁned by enzymatic or electrocardiographic documenta-
tion during hospital admission. Only one event, the most
serious in the above order, was tabulated for each patient.
Statisticalanalysis
Continuous variables are presented as median value
with 25th and 75th percentiles and comparisons between
groups were made with the Mann-Whitney U test. Dif-
ferences between proportions were assessed by chi-square
analysis. Spearman’s rank correlation method was used to
correlate TNF-α levels with ischemic time and extent of
jeopardized myocardium (expressed as summation of ST-
segment elevation before intervention).
To identify the independent determinants of myocar-
dialreperfusioninjury,logistic regressionanalysiswasap-
pliedincludinginﬂammatoryparameters,age,presenceof
diabetes, total ischemic time, Killip class, extent of jeop-
ardized myocardium, use of adjunctive therapy with gly-
coprotein IIb/IIIa inhibitors and stents, diameter stenosis
post PCI, and extent of coronary artery disease. A P value
<. 05 was considered statistically signiﬁcant.
RESULTS
Characteristicsofstudypopulation
A total of 37 AMI patients showed ECG signs of good
reperfusion whereas 28 AMI patients had ECG signs of
reperfusion injury. Table 1 summarizes the baseline char-
acteristics of these two study groups. Patients with reper-
fusion injury, as compared to patients with good reperfu-
sion, were older and were admitted more frequently with
cardiac failure or cardiogenic shock (cf Killip class > 1).
Total ischemic time was longer in patients with reper-
fusion injury and more patients with reperfusion injury2005:6 (2005) Systemic Inﬂammation and Reperfusion Injury 387
Table 1. Baseline characteristic. Data are presented as median value with 25th and 75th percentiles.
Variable Impaired reperfusion (n = 28) Good reperfusion (n = 37) P value
Age (y) 69 (53,75) 60 (55,66) .17
Men 24 (86%) 29 (78%) .4
Hypertension 16 (57%) 20 (54%) .8
Cholesterolemia > 220mg% 15 (45%) 16 (44%) .5
Lipid-lowering therapy 4 (15%) 7 (19%) .7
Diabetes mellitus 4 (14%) 2 (5%) .2
Current smoker 11 (39%) 14 (38%) .9
Killip class > 1 5 (18%) 0 (0%) .01
Total ischemic time (s) 270 (180, 382) 180 (150, 285) .01
Thrombolysis 14 (50%) 17 (47%) .8
Systolic pressure (mmHg) 130 (110, 141) 120 (106, 137) .6
GP IIb/IIIa inhibitor 13 (48%) 25 (67%) .1
Multivessel coronary disease 11 (39%) 17 (46%) .6
Infarct coronary artery — — —
RCA/LAD/CX (%) 46/46/8 33/40/27 .1
TIMI ﬂow pre-PCI, 0/1/2/3 (%) 54/7/21/18 46/13/21/18 .8
TIMI ﬂow post-PCI 2/3 (%) 44/56 14/86 .005
MBG post-PCI, 0/1/2/3 (%) 7/50/39/3 0/17/44/39 .0008
%DS post-PCI 16 (10, 19) 16 (8, 20) .9
Stent use 25 (92%) 36 (100%) .1
Electrocardiogram
ST elevation pre-PCI (mm) 10 (7, 16) 12 (8, 18) .2
%ST post-PCI/pre-PCI 79 (64, 98) 19 (13, 36) <. 0001
suﬀered from diabetes mellitus. As a consequence of the
study protocol, angiographic criteria of no-reﬂow (cf my-
ocardial blush grade 0 or 1) occurred more frequently in
the study group of impaired reperfusion. On the other
hand, the use of stents and GP IIb/IIIa receptor antago-
nists tended to be higher in the patient with good reper-
fusion. There were no signiﬁcant diﬀerences among the
groups with respect to extent of jeopardized myocardium
(expressed as the magnitude of summated ST elevation
pre-intervention), presence of multivessel disease or car-
diac risk factors (besides diabetes), and the angiographic
result postintervention.
A total of 11 healthy persons (7 men) with a median
age of 56 years (51, 60) constitutes the control group and
had the following cardiac risk proﬁle: 27% arterial hyper-
tension,36%currentsmoking,27%hypercholesterolemia
(chol > 220mg%), and no diabetes.
Inﬂammatoryparametersandinfarction
Table 2 summarizes the systemic levels of pro- and
anti-inﬂammatory mediators in control subjects com-
pared to patients with acute myocardial infarction (AMI).
Levels of general markers of inﬂammation such as
leukocyte concentration and CRP were higher in AMI pa-
tients than in the control group. Also the IL-10 concen-
tration was slightly higher in AMI patients.
Within the group of AMI patients only, TNF-α dif-
fered signiﬁcantly between patients with versus without
reperfusion injury: a median value of 25 versus 13pg/mL
was observed, respectively.
From a variety of clinical, angiographic, and electro-
cardiographic baseline factors, logistic regression analysis
identiﬁed TNF-α levels as the most important indepen-
dent determinant of the occurrence of reperfusion injury
(P = .001).Otherindependentfactorsweretotalischemic
time (P = .01), extent of jeopardized myocardium ex-
pressed as the magnitude of summated ST-segment ele-
vation preintervention (P = .08), and treatment with GP
IIb/IIIa receptor antagonists (P = .08).
There was no correlation between TNF-α levels and
total ischemic time (P = .8) or extent of jeopardized my-
ocardium (P = .6).
There were no reinfarctions and cardiovascular death
occurred in two patients. Both patients belonged to the
reperfusion injury study group.
DISCUSSION
Inﬂammation is increasingly considered to be in-
volved in the pathogenesis of acute coronary syndromes
[11]. The present study demonstrates for the ﬁrst time
a strong correlation between proinﬂammatory status, in
particular TNF-α and reperfusion state after recanaliza-
tion of an occluded infarct artery. A high level of TNF-α
was found to be the most important predictor of reper-
fusion injury in our group of AMI patients, even more388 Fien Blancke et al 2005:6 (2005)
Table 2. Inﬂammatory status. Data are presented as median value with 25th and 75th percentiles. (a) comparison of control group
with AMI patients. (b) inﬂammatory parameters of AMI patients with impaired reperfusion as compared to AMI patients with good
reperfusion.
(a)
Variable Control (n = 11) Infarction (n = 65) P value
Leucocytes, x1000/mL 7.2( 6 .6, 8.2) 9.3( 8 .2, 12.1) .0015
CRP, mg/dL 0.1( 0 .08, 0.15) 0.24 (0.09, 0.66) .03
TNF-α, pg/mL 17 (11, 22) 20 (11, 26) .5
IL-10, pg/mL 0 (0, 0) 0 (0, 18) .01
IL- ra1, pg/mL 1027 (702, 1359) 1077 (668, 2290) .5
(b)
Variable Impaired reperfusion (n = 28) Good reperfusion (n = 37) P value
Leucocytes, x1000/mL 9.3( 8 .1, 12.4) 10.0( 8 .1, 12.4) .7
CRP, mg/dL 0.19 (0.07,0.7) 0.27 (0.1, 0.6) .6
TNF-α, pg/mL 25 (21, 39) 13 (7, 20) .0001
IL-10, pg/mL 0 (0, 12) 0.7 (0, 21) .4
IL- ra1 1093 (840, 1713) 978 (538, 2600) .8
important than previously established determinants such
as the extent and duration of ischemia.
Reperfusion injury is characterised by an impairment
of microcirculatory ﬂow and by ongoing ischemia and
tissue necrosis. Evidence has accumulated that progres-
sive capillary plugging by leukocytes causing capillary no-
reﬂow and superoxide radical formation plays a role in
this reperfusion injury. Recruitment of neutrophils is reg-
ulated through a complex sequence of molecular steps in-
volving the selectins and integrins, which mediate leuko-
cyte rolling and adhesion to the endothelium [6, 12].
There is experimental evidence that cytokines such as
IL-1 and TNF-α are involved in this early stage of neu-
trophil inﬁltration by induction of endothelial adhesion
molecules [13].
In addition TNF-α may increase the production of re-
active oxygen species (ROS) and may so amplify the cas-
cade of local inﬂammatory response contributing to my-
ocardialreperfusioninjury[14].TNF-αisaproinﬂamma-
tory cytokine that has been implicated in the pathogene-
sis of cardiovascular disease, including chronic heart fail-
ure,atherosclerosis,sepsis-associatedcardiacdysfunction.
TNF-α is also produced at the site of ischemia and con-
tributesinalaterstagetomyocardialdysfunctionandcar-
diomyocyte death in ischemia-reperfusion injury via di-
rect depression of contractility and induction of myocyte
apoptosis [15]. One might argue that the observed ele-
vatedTNF-αlevels in our patients with reperfusioninjury
are a consequence of higher local production of TNF-α in
these patients. However previous work of Neumann et al
has shown that local cardiac release of cytokines during
reperfusion is too small to aﬀect systemic concentrations
in the acute phase of myocardial infarction [16]. In ad-
dition no correlation was found between the TNF-α level
and the extent or duration of ischemia.
Beyond proinﬂammatory mediators, we have also
measured some anti-inﬂammatory cytokines that have
been implicated in other cardiovascular disease (IL-10
and IL-1ra) [17]. We could not demonstrate any diﬀer-
ence among the study groups in our study. This may sug-
gest that those cytokines are not directly involved in the
earlystageofreperfusioninjury.Itshouldhoweverbeem-
phasized that the net eﬀect of any cytokine is dependent
onmanyfactorssuchasthepresenceofcompetingorsyn-
ergistic elements or the timing of release which could not
be controlled or measured in the clinical setting of this
study.
The results of this study should be considered in the
light of a few limitations.
Among potential inﬂammatory triggers in AMI, this
study investigated only a limited number of cytokines
(TNF-α, IL-10, IL-1ra). Obviously, a number of addi-
tional mediators such as cellular adhesion molecules or
othercytokinessuchastheIL-6,IL-8,IL-1maycontribute
to the phenomenon of reperfusion injury and remain to
be elucidated.
ST-segment resolution was applied to deﬁne reperfu-
sion injury. The use of other techniques such as contrast
echocardiography or angiography (cf myocardial blush
grade) could have changed the distribution of the studied
patients. However, previous studies have demonstrated a
good correlation between those diﬀerent diagnostic tools
and reanalysis of TNF-α levels using myocardial blush
grade as marker of reperfusion injury did not aﬀect the
main results [18].
In conclusion, systemic inﬂammation, in particular
high level of TNF-α, is strongly associated with the occur-
rence of reperfusion injury after successful recanalization.
OurﬁndingssuggestthatTNF-αisinvolvedinthetrigger-
ing and/or ampliﬁcation of local inﬂammatory responses2005:6 (2005) Systemic Inﬂammation and Reperfusion Injury 389
related to ischemia-reperfusion injury. TNF-α may repre-
sent a new target for therapeutic intervention in patients
with acute myocardial infarction.
REFERENCES
[1] Verma S, Fedak PW, Weisel RD, et al. Fundamen-
talsofreperfusioninjuryfortheclinicalcardiologist.
Circulation. 2002;105(20):2332–2336.
[2] ClaeysMJ, Bosmans J, Veenstra L, Jorens P, DeRaedt
H, Vrints CJ. Determinants and prognostic implica-
tions of persistent ST-segment elevation after pri-
mary angioplasty for acute myocardial infarction:
importance of microvascular reperfusion injury
on clinical outcome. Circulation. 1999;99(15):1972–
1977.
[3] Kloner RA, Ganote CE, Jennings RB. The “no-
reﬂow” phenomenon after temporary coronary oc-
clusion in the dog. JC l i nI n v e s t .1974;54(6):1496–
1508.
[4] Ambrosio G, Tritto I. Reperfusion injury: experi-
mental evidence and clinical implications. Am Heart
J. 1999;138(2 pt 2):S69–S75.
[5] Kloner RA, Giacomelli F, Alker KJ, Hale SL,
Matthews R, Bellows S. Inﬂux of neutrophils
into the walls of large epicardial coronary arter-
ies in response to ischemia/reperfusion. Circulation.
1991;84(4):1758–1772.
[6] Vermeiren GL, Claeys MJ, Van Bockstaele D, et al.
Reperfusion injury after focal myocardial ischaemia:
polymorphonuclear leukocyte activation and its
clinical implications. Resuscitation. 2000;45(1):35–
61.
[7] van ’t Hof AW, Liem A, de Boer MJ, Zijlstra F. Clini-
cal value of 12-lead electrocardiogram after success-
ful reperfusion therapy for acute myocardial infarc-
tion. Lancet. 1997;350(9078):615–619.
[8] Feldman LJ, Coste P, Furber A, et al. Incomplete
resolution of ST-segment elevation is a marker of
transient microcirculatory dysfunction after stent-
ing for acute myocardial infarction. Circulation.
2003;107(21):2684–2689.
[9] Claeys MJ, Vrints CJ, Bosmans JM, Conraads
VM, Snoeck JP. Aminophylline inhibits adaptation
to ischaemia during angioplasty. Role of adeno-
sine in ischaemic preconditioning. Eur Heart J.
1996;17(4):539–544.
[10] van ’t Hof AW, Liem A, Suryapranata H, Hoorn-
tje JC, de Boer MJ, Zijlstra F. Angiographic as-
sessment of myocardial reperfusion in patients
treated with primary angioplasty for acute myocar-
dial infarction: myocardial blush grade. Circulation.
1998;97(23):2302–2306.
[11] Pearson TA, Mensah GA, Alexander RW, et al.
Markers of inﬂammation and cardiovascular dis-
ease: application to clinical and public health prac-
tice: A statement for healthcare professionals from
the Centers for Disease Control and Prevention
and the American Heart Association. Circulation.
2003;107(3):499–511.
[12] Frangogiannis NG, Smith CW, Entman ML. The in-
ﬂammatory response in myocardial infarction. Car-
diovasc Res. 2002;53(1):31–47.
[13] Dinarello CA. Proinﬂammatory cytokines. Chest.
2000;118(2):503–508.
[ 1 4 ]N i a nM ,L e eP ,K h a p e rN ,L i uP .I n ﬂ a m m a t o r yc y -
tokines and postmyocardial infarction remodeling.
Circ Res. 2004;94(12):1543–1553.
[15] Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A,
Vooletich MT, Farmer JA, Torre-Amione G. Tu-
mor necrosis factor-alpha: a mediator of disease
progression in the failing human heart. Chest.
1999;115(4):1170–1174.
[16] NeumannFJ,OttI,GawazM,etal.Cardiacreleaseof
cytokines and inﬂammatory responses in acute my-
ocardialinfarction.Circulation.1995;92(4):748–755.
[17] Opal SM, DePalo VA. Anti-inﬂammatory cytokines.
Chest. 2000;117(4):1162–1172.
[18] Angeja BG, Gunda M, Murphy SA, et al. TIMI my-
ocardial perfusion grade and ST segment resolu-
tion: association with infarct size as assessed by sin-
gle photon emission computed tomography imag-
ing. Circulation. 2002;105(3):282–285.